EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - Politician Trades
eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of May 21, 2026, EXOZ trades at $9.40 with a market cap of $80.97M and a P/E ratio of -8.83. EXOZ moved -2.11% today. Year to date, EXOZ is -15.50%; over the trailing twelve months it is -10.22%. Its 52-week range spans $7.08 to $23.99. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded EXOZ stock?
Rallies tracks politician and congressional stock disclosures for EXOZ, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Korman Tyler Paz sold 750 (~$7.89K) on Apr 9, 2026.
Korman Tyler Paz sold 750 (~$7.53K) on Apr 8, 2026.
Heltzen Michael bought 1.04K (~$10.63K) on Jul 2, 2025.
EXOZ Analyst Consensus
EXOZ analyst coverage data. Average price target: $0.00.
Common questions about EXOZ
Which politicians traded EXOZ stock?
Rallies tracks politician and congressional stock disclosures for EXOZ, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in EXOZ?
Yes. Rallies tracks politician and congressional stock disclosures for EXOZ, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EXOZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.